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ABSTRACT
Nitric oxide (NO) induces deamination of guanine,
yielding xanthine and oxanine (Oxa). Furthermore,
OxareactswithpolyaminesandDNAbindingproteins
to form cross-link adducts. Thus, it is of interest how
these lesions are processed by DNA repair enzymes
in view of the genotoxic mechanism of NO. In the pre-
sent study, we have examined the repair capacity for
Oxa and Oxa–spermine cross-link adducts (Oxa–Sp)
of enzymes involved in base excision repair (BER)
and nucleotide excision repair (NER) to delineate
the repair mechanism of nitrosative damage to guan-
ine. Oligonucleotide substrates containing Oxa and
Oxa–Sp were incubated with purified BER and NER
enzymesorcell-freeextracts(CFEs),andthedamage-
excising or DNA-incising activity was compared with
that for control (physiological) substrates. The Oxa-
excising activities of Escherichia coli and human
DNA glycosylases and HeLa CFEs were 0.2–9% relat-
ivetocontrolsubstrates,implyingpoorprocessingof
OxabyBER.Incontrast,DNAcontainingOxa–Spwas
incised efficiently by UvrABC nuclease and SOS-
induced E.coli CFEs, suggesting a role of NER in
amelioratinggenotoxiceffectsassociatedwithnitros-
ative stress. Analyses of the activity of CFEs from
NER-proficient and NER-deficient human cells on
Oxa–Sp DNA confirmed further the involvement of
NER in the repair of nitrosative DNA damage.
INTRODUCTION
The DNA molecules that carry the vital genetic information of
cells continuously suffer from spontaneous decay due to
exposure to water (1,2). Together with the most frequently
occurring depurination (3,4), hydrolytic deamination of DNA
bases takes place at slower but non-negligible rates (4,5).
Deamination of DNA bases is further accelerated by nitros-
ative stress by nitric oxide (NO) and nitrous acid (6–9), in
which nitrous anhydride isbelieved tobe akeymediator.Ithas
been postulated that in tissues with chronic inﬂammation, a
high ﬂux of NO secreted by activated macrophages can induce
nitrosative damage to DNA in normal cells, thereby increasing
cancer risk associated with chronic inﬂammation (10–13).
Nitrosative deamination of cytosine and adenine results in
uracil and hypoxanthine (Hx), respectively. Uracil is repaired
by the base excision repair (BER) pathway initiated by uracil-
DNA glycosylase both in prokaryotic and eukaryotic cells
(1,14,15), and a putative mammalian backup enzyme for
uracil-DNA glycosylase has been identiﬁed (16,17). Hx is also
repaired by the BER pathway initiated by 3-methyladenine-
DNA glycosylase II (AlkA) and methylpurine-DNA glyco-
sylase (MPG) in prokaryotic and eukaryotic cells, respectively
(15,18,19). Unlike cytosine and adenine, nitrosative deamina-
tion of guanine gives rise to two products, xanthine (Xan) and
oxanine (Oxa), via deamination of the 2-NH2 group followed
by ring opening and rearrangement (20–23) [for a conﬂicting
result, see Ref. (24)]. Furthermore, Oxa but not Xan reacts
with polyamines such as spermine and spermidine and DNA
binding proteins such as histone and DNA glycosylases, form-
ing cross-link adducts (25).
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doi:10.1093/nar/gki513In Escherichia coli, Xan is repaired either by the BER
pathway involving AlkA (26,27) or by an alternative repair
pathway involving endonuclease (Endo) V (15,28). Mamma-
lian MPG, a functional homolog of AlkA, has been shown to
excise Xan from DNA (27), indicating a similar BER pathway
for the repair of Xan in mammalian cells. Although a human
homolog of Endo V has been identiﬁed (29), it has not been
tested for Xan. In contrast, very little is known about the repair
of Oxa and its cross-link adducts (26,30,31).
In the present study, we examined systematically the exci-
sion capacity for Oxa and Oxa–spermine cross-link adducts
(Oxa–Sp) of BER and nucleotide excision repair (NER)
systems to delineate the repair mechanisms of these lesions.
We report here that Oxa is a very poor substrate for E.coli and
human DNA glycosylases and UvrABC nuclease. In contrast,
Oxa–Sp is excised efﬁciently by UvrABC but not by DNA
glycosylases, suggesting a role of NER in ameliorating geno-
toxic effects associated with nitrosative stress. The analyses of
the activity of cell-free extracts (CFEs) from E.coli and human




The control oligonucleotide substrates used for the activ-
ity assay of BER enzymes (Table 1) were prepared by the
phosphoramidite method (uracil, Hx and 7,8-dihydro-8-
oxoguanine) or as reported previously [7-methylguanine
(7mG), thymine glycol and an abasic (AP) site] (32,33).
25OXA (Figure 1A) was prepared as described previously
(25). The oligonucleotide substrates used for the assay of
NER activities are shown in Figure 1B and C. 60OXAe and
60OXAi carrying 50-end and internal
32P-labels (Figure 1B),
respectively, were prepared by DNA polymerase reactions
using appropriate templates, primers, 20-deoxyoxanosine
50-triphosphate and normal dNTPs (25). Brieﬂy, in the
preparation of 60OXAe, a 50-end
32P-labeled 30mer primer
was extended on a 60mer template with 20-deoxyoxanosine
50-triphosphate followed by normal dNTPs. For the prepara-
tion of 60OXAi, an unlabeled 30mer primer was extended
similarly with 20-deoxyoxanosine 50-triphosphate followed
by dNTPs containing [a-
32P]dCTP so that the region 30
to Oxa was uniformly labeled by [
32P]dCMP (Figure 1B).
60FLcontainingﬂuorescein(FL)wassynthesizedbythe phos-
phoramidite method using the corresponding monomer unit
(Glen Research). The bottom strand of 150OXA (150mer
template, Figure 1C) was prepared by the enzymatic ligation
of three 50mer fragments. The 80mer primer for the synthesis
of the top strand of 150OXA was similarly prepared by the
ligation of two 40mer fragments. 150OXAe and 150OXAi
carrying 50-end and internal
32P-labels (Figure 1C), respect-
ively, were prepared by DNA polymerase reactions using the
150mer template and the 80mer primer as described for
60OXA substrates. 150FL was prepared by enzymatic ligation
of 60FL and 40mer and 50mer fragments. 60OXA–SPe,
60OXA–SPi, 150OXA–SPe and 150OXA–SPi containing
an Oxa–Sp cross-link adduct were prepared by the reaction
of 60OXAe, 60OXAi, 150OXAe and 150OXA–SPi with
spermine, respectively (25). Markers for the analysis of
human NER products (Figure 1C) were prepared by ligation
(59mer and 64mer) or DNA polymerase reactions followed by
spermine modiﬁcation (27mer bearing Oxa–Sp).
Enzymes and cells
E.coli uracil-DNA glycosylase was obtained from New
England Biolabs. Other DNA glycosylases (AlkA, Endo III,
EndoVIII,andformamidopyrimidine-DNAglycosylase(Fpg))
and an AP endonuclease (Endo IV) from E.coli and those from
humans [single-strand-selective monofunctional uracil-DNA
glycosylase (hSMUG1), an Endo III homolog (hNTH1),
Endo VIII homologs (hNEIL1 and hNEIL2), 8-oxoguanine-
DNA glycosylase (hOGG1)] were from laboratory stock, and
puriﬁcation of these enzymes has been described elsewhere
(32–38).ThehMPGproteinlacking1–79residuesbutretaining
N-glycosylase activity (39) was a gift from Dr Saparbaev. The
UvrA, UvrB and UvrC proteins from Bacillus caldotenax,
a thermophilic bacterium, were overexpressed in E.coli and
puriﬁed as reported previously (40,41).





19U U ACAGACGCCAXCAACCAGG Ung, hSMUG1
TGTCTGCGGTGGTTGGTCC
34MG 7mG GAAACACTACTXTCACCCTCCATACCCACATCCT AlkA, hMPG
CTTTGTGATGACAGTGGGAGGTATGGGTGTAGGA
25HX Hx GAAACACTATTCCACXCCTTCTCTC HeLa CFE1s, hMPG
CTTTGTGATAAGGTGTGGAAGAGAG
19TG Tg ACAGACGCCAXCAACCAGG Endo III, Endo VIII
TGTCTGCGGTAGTTGGTCC hNTH1, hNEIL1
25OG 8oxoG CATCGATAGCATCCTXCCTTCTCTC Fpg, hOGG1
GTAGCTATCGTAGGACGGAAGAGAG
19AP AP ACAGACGCCAXCAACCAGG Endo IV, hNEIL2
TGTCTGCGGTGGTTGGTCC
aU, uracil; 7mG, 7-methylguanine; Hx, hypoxanthine: Tg, thymine glycol; 8oxoG, 7,8-dihydro-8-oxoguanine; AP, abasic site.
bTop strands containing damage were 50-end
32P-labeled.
cReaction buffer used: 20 mM Tris–HCl (pH 8.0), 1 mM EDTA and 1 mM DTT (Ung); 25 mM Tris–HCl (pH 7.5), 50 mM NaCl, 0.2 mM EDTA and 2 mM DTT
(hSMUG1);50mMHEPES–KOH(pH7.5),1mMEDTAand5mM2-mercaptoethanol(AlkA);50mMHEPES–KOH(pH7.5),100mMNaCl,1mMEDTA,5mM
2-mercaptoethanol(hMPGandHeLaCFE1s);10mMTris–HCl(pH7.4),100mMNaCland1mMEDTA(EndoIII,EndoVIII,FpgandhNEIL1);10mMTris–HCl
(pH7.5), 50mM NaCland1mMEDTA (EndoIV andhNEIL2);and50 mMTris–HCl(pH7.5), 50mM NaCl,1mMEDTA and1 mMDTT (hOGG1andhNTH1).
2182 Nucleic Acids Research, 2005, Vol. 33, No. 7E.coli strains AB1157 (wild type with respect to repair
capacity), BW9109 (xth) and RPC501 (xth nfo) were gifts
from Dr Yonei and originally from Dr Weiss (42,43). The
genotype of AB1157 is F
  thr-1 ara-14 leuB6(Am) lacY1
D(gpt-proA2)62 tsx-33 supE44(Am) galK2 rac hisG4(Oc)
rfbD1 mgl-51 rpsL31 kdgK51 xyl-5 mtl-1 argE3(Oc) thi-1,
and those of BW9109 and RPC501 are the same as AB1157
but also include D(xthA-pncA) and D(xthA-pncA) nfo-1::kan,
respectively. HeLa cells were from laboratory stock. NER-
deﬁcient xeroderma pigmentosum (XP) cells transformed
by SV40 [XP2OS(SV) (complementation group A) and
XP2YO(SV) (complementation group F)] (44,45) were
obtained from the Health Science Research Resource Bank
(http://www.jhsf.or.jp).
Activity assays with BER enzymes
50-end
32P-labeled 25OXA or a control substrate (all 2 nM)
was incubated with BER enzymes (10 and 100 ng) in an
appropriate buffer (10 ml, Table 1) at 37 C for 30 min.
Figure 1. Substrates containing Oxa and Oxa–Sp. (A) Substrates for BER enzymes and human CFE1s. (B) NER substrates for UvrABC and E.coli CFEs.
(C) NER substrates for human CFE2s. The abbreviations of substrates, damage (X) and the positions of
32P-labels are shown in tables under the sequences.
The phosphodiester bonds incised by UvrABC and E.coli and human CFEs are indicated by vertical arrows. The sequences of oligonucleotides used as markers are
indicated by horizontal arrows.
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cyanol, 0.05% bromophenol blue, 20 mM EDTA and
98% formamide), heated and separated by 16% denaturing
PAGE. Radioactivity in the gel was analyzed on a phosphor-
imaging analyzer Fuji BAS 2000. For monofunctional DNA
glycosylases (Ung, AlkA, hSMUG1 and hMPG), the sample
was mixed with 1 M NaOH (ﬁnal concentration 0.1 M) after
incubation with enzymes, heated brieﬂy at 90 C to cleave AP
sites, neutralized with 1 M acetic acid and subjected to PAGE
analysis. For the analysis of enzymatic parameters, 50-end
32P-labeled 25OXA and 25Hx (both 5–60 nM) were incubated
with hMPG (0.6 ng) for 20 min, and products were analyzed as
described above. The parameters (kcat and Km) were evaluated
from Lineweaver–Burk plots.
Activity assays with UvrABC
The substrates containing Oxa (60OXAe and 60OXAi),
Oxa–Sp (60OXA–SPe and 60OXA–SPi), FL (60FL) and
G (60G) (all 2 nM) were incubated with UvrABC (20 nM
UvrA, 60 nM UvrB and 50 nM UvrC) in UvrABC buffer
[50 mM Tris–HCl (pH 7.5), 10 mM MgCl2, 50 mM KCl,
1 mM ATP and 5 mM DTT; total 20 ml] at 37 or 55 C for
1 h. The reaction was terminated by the addition of EDTA
(ﬁnal concentration 20 mM). The sample was heated at 95 C
for 5 min and separated by 12% denaturing PAGE. Products
were quantitated as described above.
Preparation of E.coli and human CFEs
E.coli cells were grown in 200 ml Luria–Bertani (LB) media
(AB1157 and BW9109) or LB media supplemented with
50 mg/ml kanamycin (RPC501) until OD600 reached 0.5.
Cells were harvested by centrifugation and suspended in
10 ml LB media. Half the suspended cells were irradiated
with a UV lamp (40 J/m
2) to induce the SOS response (46).
The UV-irradiated and unirradiated cells were incubated
at 37 C for 40 min with shaking. The cell suspension was
mixed with an equal volume of 100 mM NaCl, 10 mM
Tris–HCl (pH 8.0) and 10 mM EDTA,and cells were collected
by centrifugation. The collected cells were suspended in
10 volumes of lysis buffer [10 mM Tris–HCl (pH 8.0),
1 mM EDTA, 1 mM phenylmethanesulfonyl ﬂuoride
(PMSF) and 0.1 mg/ml lysozyme] and kept on ice for
30 min. The cells were disrupted by sonication (70 W,
15 s · 4) at an ice-cold temperature and centrifuged at
10000 g for 15 min. The supernatant was recovered and
used for activity assays. The protein concentration was
determined with the BCA protein assay kit (Pierce).
CFEs from HeLa, XPA and XPF cells were prepared
according to the reported procedure (47). Brieﬂy, cells were
grown in a Dulbecco’s modiﬁed Eagle medium supplemented
with 10% fetal calf serum at 37 C in a 5% CO2 atmosphere
until they became conﬂuent. CFEs were prepared on ice or at
4 C. Harvested cells ( 1 ml as wet cells) were washed twice
with phosphate-buffered saline, suspended in 4 ml of hypo-
tonic buffer [10 mM Tris–HCl (pH 8.0), 1 mM EDTA and
5 mM DTT], and kept standing for 20 min. To the suspension,
protease inhibitorswere added (0.5 mM PMSF, 0.5mg/ml each
of leupeptin, pepstatin and chymostatin), and cells were dis-
rupted with a Dounce homogenizer. The disrupted cells were
centrifuged at 100000 gfor 30 min, and part of the supernatant
(designated as CFE1s) was used for BER activity assays. The
rest of supernatant was mixed with 4 ml of 50 mM Tris–HCl
(pH 7.5), 10 mM MgCl2, 2 mM DTT, 25% sucrose and 50%
glycerol. Proteins were precipitated by ammonium sulfate,
and those precipitated between 10 and 80% saturation were
recovered, dissolved in 25 mM HEPES–KOH (pH 7.9),
0.1 M KCl, 12 mM MgCl2, 1 mM EDTA, 2 mM DTT and
17% glycerol, and dialyzed against the same buffer (4 h · 3).
The sample was centrifuged at 125000 g for 10 min, and the
supernatant (designated as CFE2s) was stored as aliquots at
 80 C and used for NER activity assays. The protein con-
centration of CFE1s and CFE2s was determined as above.
BER and NER activity assays with CFEs
In the assays for BER activity with human CFEs, 25OXA and
25HX(both2nM)wereincubatedwithHeLaCFE1s(1or5mg)
in hMPG buffer (10 ml, Table 1) at 37 C for 1 h, and products
were analyzed as described for hMPG. In the assays for lesion
excision by NER with E.coli CFEs, 60OXA–SPe (2 nM) was
incubated with CFEs (2–10 mg) from E.coli AB1157, BW9109
and RPC501 in UvrABC buffer (10 ml) at 37 C for 15 min.
Products were separated and quantitated as described for
UvrABC.TheNERassayswith humanCFE2swere performed
by following a reported procedure (47). 150OXAe, 150OXAi,
150OXA–SPe, 150OXA–SPi or 150FL (all 2 nM) was incub-
ated with human CFE2s (100 mg) in 40 mM HEPES–KOH
(pH 7.9), 70 mM KCl, 8 mM MgCl2, 0.3 mM EDTA, 1.2 mM
DTT, 2 mM ATP, 10% glycerol, 20 mM each of four dNTPs
and 0.1 mg/ml BSA (total 50 ml) at 30 C for 90 min. For
complementation experiments, a mixture of CFE2s from
XPA (50 mg) and XPF (50 mg) cells was used for NER activity
assays. After incubation, protease K (Wako) was added at the
ﬁnal concentration of 0.2 mg/ml, and incubation was contin-
ued at 37 C for 15 min. The sample was extracted by phenol,
and DNA was recovered by ethanol precipitation. Products
were separated by 10% denaturing PAGE and quantitated
as described for UvrABC.
RESULTS
Activity of BER enzymes for Oxa and Oxa–Sp
To assess the repair activity for Oxa systematically, ﬁve E.coli
and six human DNA glycosylases (10 or 100 ng) were incub-
ated with 25OXA and control substrates (all 2 nM) at 37 C for
30 min and products were analyzed by PAGE. The amounts of
enzymes used were  15-fold (10 ng) or 150-fold (100 ng)
molar excessive over the substrates so that marginal activities
for Oxa could be detected. Typical gel data for AlkA and
hMPG are shown in Figure 2A, where nicked products gen-
erated by enzyme and subsequent alkaline treatment are seen
as a mixture of b- and b,d-elimination products. AlkA and
hMPG efﬁciently removed 7mG from the control substrate
(lanes 8, 9, 17 and 18), but Oxa was removed poorly even
with copious enzymes (lanes 3 and 12). Endo VIII, Fpg and
hNEIL1 also exhibited Oxa-excising activities but they were
much weaker than those of AlkA and hMPG (gel data not
shown). Quantitation of the amount of damage excised per
ng of enzyme indicated that the activities of the DNA glyco-
sylases were 0.2–9% of those for their control (physiological)
substrates (Table 2). hMPG excised 7mG slightly better than
2184 Nucleic Acids Research, 2005, Vol. 33, No. 7Hx as control substrates. Thus, the Oxa-excising activity of
hMPG relative to Hx was higher than that relative to 7mG
(Table 2). The enzymatic parameters of hMPG for Oxa and Hx
were also evaluated for quantitative comparison of activities.
The kcat and Km values for Oxa were 2.1 · 10
 3 min
 1 and
30 nM, respectively, and those for Hx were 1.5 · 10
 2 min
 1
and 15 nM, respectively, indicating that the excisionefﬁciency
(kcat/Km) of hMPG for Oxa is 14-fold lower than that for Hx.
Several of the DNA glycosylases tested here react with Oxa
in DNA and form cross-link adducts (25,48), which could
compromise the Oxa-excising efﬁciency by limiting available
substrates or enzymes. However, the amount of DNA glyco-
sylases used here was excessive over the substrate (roughly by
15-and150-fold),andthefraction ofthecross-linkedsubstrate
was <5% under the present conditions (data not shown). Thus,
the poor activity of DNA glycosylases for Oxa was not due
to the limited availability of enzymes or substrates. We also
tested Endo IV, an E.coli AP endonuclease that has been
shown to recognize various oxidative and other base lesions
(1,49–51), but it was not found to be active for Oxa (Table 2).
Considering that BER enzymes tested here are responsible for
the repair of a wide range of base damage in cells (48,52),
their marginal activity for Oxa implies that this DNA lesion is
poorly repaired bythe BERpathwayinE.coliandhumancells.
The activity of BER enzymes for Oxa–Sp was similarly
tested using 25OXA–SP as a substrate, but none of the
enzymes showed detectable activity (Figure 2A, lanes 4–6
and 13–15, and Table 2). It is likely that BER enzymes
(DNA glycosylases) can not accommodate the bulky Oxa–
Sp lesion in the active site pocket since they generally recog-
nize relatively minor base modiﬁcations induced by oxidation,
alkylation and deamination.
Activity of UvrABC for Oxa and Oxa–Sp
The thermophilic UvrABC from B.caldotenax was used for
activity assays because of its stable and robust in vitro NER
activity (40,41). To assess the activity of UvrABC for Oxa
and Oxa–Sp, UvrABC was incubated with 60OXAe and
60OXA–SPe (both were 50-end labeled and 2 nM) at 37 C
for 1 h. Experiments with control substrates containing
G (60G) and FL (60FL) were also performed in parallel.
It has been shown that UvrABC recognizes FL, an artiﬁcial
substrate, and efﬁciently makes incisions on DNA containing
FL (41). No incision was observed for 60OXAe, indicating
that Oxa is not a substrate for UvrABC (Figure 3A, lane 7).
Figure 2. PAGE analysis of BER activities of AlkA, hMPG and HeLa CFE1s
forOxaandOxa–Sp.(A)25OXA,25OXA–SPand34MG(all2nM,Figure1A
and Table 1) were incubated with the indicated amounts of AlkA and hMPG
at 37 C for 30 min. After incubation, the reaction mixture was treated with
0.1 M NaOH to cleave AP sites, and products were separated by 16% denatur-
ing PAGE. The nicked products due to b-elimination (upper bands) and
b,d-elimination (lower bands) are indicated by open brackets. (B) 25OXA
and 25HX (both 2 nM, Figure 1A and Table 1) were incubated in hMPG buffer
with the indicated amounts of HeLa CFE1s at 37 C for 1 h. Products were
analyzed as described above.









Ung U n.d. n.d.
AlkA 7mG Weak (1%) n.d.
Endo III Tg n.d. n.d.
Endo VIII Tg Weak (0.2%) n.d.
Fpg 8oxoG Weak (0.5%) n.d.
Endo IV AP n.d. n.d.
Human
hSMUG1 U n.d. n.d.
hMPG 7mG Weak (4%) n.d.
hMPG Hx Weak (9%) n.d.
hNTH1 Tg n.d. n.d.
hNEIL1 Tg Weak (0.2%) n.d.
hNEIL2 AP n.d. n.d.
hOGG1 8oxoG n.d. n.d.
aU, uracil; 7mG, 7-methylguanine; Tg, thymine glycol; 8oxoG, 7,8-dihydro-
8-oxoguanine; AP, abasic site; Hx, hypoxanthine. The sequences of substrates
are given in Table 1.
bn.d., activity was not detectable.
cThe percentage in parentheses indicates activity relative to that for the control
substrate.
Nucleic Acids Research, 2005, Vol. 33, No. 7 2185Figure 3. Analysis of NER activities of UvrABC and E.coli CFEs for Oxa and Oxa–Sp. (A) 60G, 60OXAe, 60OXA–SPe and 60FL (all 2 nM and 50-end labeled,
Figure 1B) were incubated with UvrABC (20 nM UvrA, 60 nM UvrB and 50 nM UvrC) at 37 C for 1 h. Products were analyzed by 12% denaturing PAGE. The
sequence of the 23mer marker is given in Figure 1B. (B) 60OXAi and 60OXA–SPi (all 2 nM and internally labeled, Figure 1B) were incubated with UvrABC, and
products were analyzed as in panel A. The sequences of the 12mer and 25mer markers are given in Figure 1B. (C) 60OXA–SPe and 60 FL were incubated with
UvrABC asdescribed in panel A forup to 30 min. The amountsof 50 incisionproducts are plottedagainst incubationtime. Symbols:circles, Oxa–Sp; triangles,FL.
(D) 60OXA–SPe (2 nM) was incubated at 37 C for 15 min with CFEs (2, 5 and 10 mg) from E.coli BW9109 (xth) and RPC501 (xth nfo) that were pre-irradiated
without ( SOS) or with (+SOS) UV. Products were analyzed as in panel A.
2186 Nucleic Acids Research, 2005, Vol. 33, No. 7In contrast, the PAGE analysis of products for 60OXA–SPe
and 60FL revealedincision products (lanes 8and 9), whose gel
mobilities were comparable to that of a 23mer marker (lane 1,
see also Figure 1B for the sequence). Thus, UvrABC made an
incision at the 8th phosphodiester bond 50 to Oxa–Sp and FL.
Considering that the UvrABC proteins are from a thermo-
philic bacterium, UvrABC was also incubated with substrates
at 55 C. However, the increase in temperature led to no sig-
niﬁcant increase in the activity. To clarify whether UvrABC
introduced an additional 30 incision, 60OXAi and 60OXA–SPi
carrying internal labels (Figure 1B) were similarly incubated
with UvrABC, and products were analyzed by PAGE. Again
no incision was observed for 60OXAi (Figure 3B, lane 4).
For 60OXA–SPi, two labeled fragments were generated
(lane 6). The gel mobility of a large fragment was compar-
able to that of a 25mer marker (lane 1, see also Figure 1B
for the sequence), indicating an incision at the 5th phospho-
diester bond 30 to Oxa–Sp. The small fragment was a
dual incision product, a 12mer bearing an Oxa–Sp adduct
(Figure 1B), and it migrated slower than a 12mer marker
without damage (Figure 3B, lane 1). It is noted that the par-
ental oligonucleotidecontainingOxa–Spalso exhibited slower
gel mobility than those containing G or Oxa (Figure 3A,
lanes 2–4). All components of UvrABC were essential for
the incision of substrates containing Oxa–Sp so that no
incision occurred in the absence of either UvrA, UvrB or
UvrC (data not shown).
60OXA–SPe and 60FL were incubated with UvrABC for up
to 30 min, and activities for Oxa–Sp and FL were quantitat-
ively compared by following the time course of incision. The
amount of incision products for Oxa–Sp was approximately
two-thirds of that for FL throughout the reaction (Figure 3C).
Considering that FL serves as a good substrate for UvrABC
(41), the present result indicates that Oxa–Sp is a fairly good
substrate for UvrABC.
Activity of human CFE1s for Oxa
25OXA and 25HX (2 nM) were incubated with HeLa CFE1s
(1 and 5 mg) in hMPG buffer at 37 C for 1 h, and reaction
products were subjected to alkaline treatment to cleave AP
sites. PAGE analysis of products revealed that Hx was efﬁ-
ciently removed by HeLa CFE1s (Figure 2B, lane 5), whereas
Oxa was removed very poorly (lanes 2 and 3). The amount of
Oxa excised from DNA (per mg of CFE1s) was at most a few
percentage points of that of Hx, in keeping with the result with
puriﬁed hMPG (Table 2).
Activity of E.coli CFEs for Oxa–Sp
60OXA–SPe was incubated with E.coli CFEs, and products
were analyzed by PAGE. When 60OXA–SPe (2 nM) was
incubated with CFEs (2–10 mg) from E.coli AB1157 (xth
wild type) in UvrABC buffer containing Mg
2+, the substrate
was degraded exonucleolytically (data not shown). Thus, it
was not clear whether damage-speciﬁc incision occurred on
the substrate. However, when 60OXA–SPe was incubated
with CFEs from SOS-induced BW9109 or RPC501 (both xth
mutants), speciﬁc incision products were observed (Figure 3D,
lanes 6–8 and 12–14). These incision products were 23mers
(lane 1), indicating that the incision site with the CFEs was the
same as that with UvrABC (Figure 3A). The incision was
dependent on the SOS response (i.e. UV-induction of UvrA
and UvrB proteins) so that no obvious incision occurred with
CFEs without SOS induction (Figure 3D, lanes 3–5 and 9–11).
These results indicate that DNA containing Oxa–Sp is specif-
ically incised by cellular UvrABC and probably repaired by
the NER pathway.
NER activity of human CFEs for Oxa–Sp
The NER activity of human cells for Oxa–Sp was initially
examined using 150OXA–SPe together with 150OXAe and
150FL as control substrates (Figure 1C). The substrates (2 nM)
were incubated with HeLa CFE2s (100 mg) at 30 C for up to
90 min, and products were analyzed by PAGE. Although no
incision was observed with 150OXAe (Figure 4A, lanes 2–5),
150OXA–SPe and 150FL were incised by HeLa CFE2s
(lanes 6–13). The cleavage pattern of DNA was similar for
150OXA–SPe and 150FL. The incision products were tentat-
ively assigned as 54mer and 58–60mers by comparison with
the gelmobility ofa 59mermarker (lane 1), suggesting that the
21st–23rd and 27th phosphodiester bonds 50 to the lesions
were cleaved (Figure 1C). Figure 4B shows the relationship
between incubation time and the amount of 50 incision pro-
ducts for 150OXA–SPe and 150FL, which reveals that HeLa
CFE2s exhibit comparable activities for Oxa–Sp and FL.
To analyze additional 30 incisions, 150OXA–SPi carrying
internal labels (Figure 1C) was similarly incubated with
HeLa CFE2s. Product analysis by PAGE revealed labeled
fragments indicative of damage-speciﬁc 30 and dual incisions
by NER (indicated by asterisks in Figure 4C) together with
other fragments (indicated by dots). Considering the different
speciﬁc radioactivities of damage-speciﬁc incision products
(Figure 1C), the yields of 30 and dual incision products
were virtually comparable, indicating coupled incisions on
both sides of Oxa–Sp. These products exhibited gel mobilities
comparable to those of a 64mer marker and a 27mer bearing
Oxa–Sp (lanes 1 and 2), respectively. More detailed size ana-
lyses of damage-speciﬁc incision products by long electro-
phoresis showed that incisions occurred at the 4th–7th
phosphodiester bonds 30 to Oxa–Sp (Figure 1C) and that dual
incision products were 26merand27merinsize.Theoriginsof
two other fragments (indicated with dots in Figure 4C) were
unknown, but the estimated size of large one ( 92mer)
implied that it was generated by a rarely occurring uncoupled
50 incision. The human NER complex generally incises the
16th–26th phosphodiester bonds on the 50 side and the 4th–
10th bonds on the 30 side of a lesion, resulting in 24–32mer
fragments bearing a lesion (1,53–55). Thus, coupled incisions
on the 50 and 30 sides of Oxa–Sp observed here are hallmarks
of the human NER system. To conﬁrm the involvement of
NER further, activity complementation experiments were
performed with CFE2s from NER-deﬁcient XPA and XPF
cells. 150OXA–SPe was incubated with CFE2s and products
were analyzed by denaturing PAGE (Figure 4D). Damage-
speciﬁc 50 incisions indicative of NER were not observed
with CFE2s from XPA and XPF cells (lanes 4 and 5). How-
ever, incision activity for Oxa–Sp was restored with the mix-
ture of CFE2s from XPA and XPF cells (lane 6), clearly
demonstrating the involvement of the NER system in the
incision of Oxa–Sp DNA.
Nucleic Acids Research, 2005, Vol. 33, No. 7 2187Figure 4. AnalysisofNERactivitiesofhumanCFE2sforOxaandOxa–Sp.(A)150OXAe,150OXA–SPeand150FL(all2nMand50-endlabeled,Figure1C)were
incubatedwithHeLaCFE2s(100mg)at30 Cfor0,20,60and90min,andproductswereanalyzedby10%denaturingPAGE.Notethattheonlygelregioncontaining
incised products is shown. The sequence of the 59mer marker is given in Figure 1C. (B) The amount of 50 incision products shown in panel A was quantitated for
Oxa–Sp(circles),FL(triangles)andOxa(squares),andareplottedagainstincubationtime.(C)150OXA–SPi(2nMandinternallylabeled,Figure1C)wasincubated
with HeLa CFE2s (100 mg), and products were analyzed as in panel A. The sequences of a 64mer marker and a 27mer bearing Oxa–Sp are given in Figure 1C.
Thefragmentsderivedfromdamage-specific30 anddualincisionsareindicatedbyasterisks.Thefragmentsfromunknownoriginareindicatedbydots(seealsotext).
(D)150OXA–SPe(2nM)wasincubatedwithCFE2s(100mg)fromHeLa,XPAandXPFcells,oramixtureofCFE2sfromXPA(50mg)andXPF(50mg)cellsat30 C
for 90 min. Products were analyzed as in panel A. The CFE2s used are indicated on the gel.
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In the present study, we have assessed systematically the Oxa-
and Oxa–Sp-excising activities of BER and NER enzymes and
CFEs to delineate the potential repair mechanisms of guanine
lesions generated by nitrosative stress. Several DNA glyc-
osylases from E.coli (AlkA, Endo VIII and Fpg) and humans
(hMPG and hNEIL1) exhibited Oxa-excising activity but the
activity was weak at only 0.2–9% of those for their physio-
logical substrates(Table 2).Theresults ofAlkAand EndoVIII
are consistent with our previous data (26). Towards the end of
this study, it was reported that mammalian MPG (also called
AAG or ANPG) acts as Oxa-DNA glycosylase (30), which
agrees qualitatively, but not quantitatively, with the present
result for hMPG. According to the reported data (30), hMPG
excises Oxa with compromised ( 30%) or comparable efﬁ-
ciencies relative to a control substrate (Hx). In addition, Oxa-
excising activity is found in CFEs from the spleen of wild-type
but not MPG-knockout mice. Conversely, we found that the
Oxa-excising activity of hMPG was much lower than that
for control substrates (4 and 9% relative to 7mG and Hx,
respectively, Table 2). The low activity for Oxa was not due
to DNA–protein cross-link formation, since hMPG did not
form cross-links with Oxa (data not shown). Consistent with
the weak activity of hMPG for Oxa, the Oxa-excising activity
of HeLa CFE1s was very weak (a few percent of the Hx-
excising activity) under the present conditions (Figure 2B).
Accordingly, we tentatively assume that Oxa is a poor sub-
strate for hMPG and therefore is not processed efﬁciently by
the BER pathway in human cells. However, further studies
are necessary to clarify whether the Oxa-excising activity of
mammalian MPG is a physiologically relevant function.
Oxa was also a poor substrate for E.coli DNA glycosylases
(Table 2), suggesting that Oxa is poorly repaired by the BER
pathway in E.coli. This is in contrast to Xan, another major
guaninelesion generatedbynitrosative stress,being efﬁciently
removed from DNA by E.coli and human DNA glycosylases
that initiate the BER process (26,27). It has been shown very
recently that prokaryotic Endo V incises Oxa-containing DNA
at the second phosphodiester bond on the 30 side of the lesion
(31). The cleavage efﬁciency is 6-fold lower than that for
Hx-containing DNA, a control substrate. In addition to Oxa,
Endo V recognizes a wide range of aberrant DNA structures
including deaminated bases (uracil, Hx and Xan), base mis-
matches and ﬂap and pseudo Y structures (15). The genetic
analysis of E.coli strains deﬁcient in Endo V suggests that
Endo V plays a role in ameliorating genotoxic effects con-
ferred by nitrous acid (56–58), and hence provides an altern-
ative repair pathway for deaminated bases. Combining the
present and previous biochemical and genetic data, it is likely
that in E.coli Xan is repaired by BER and/or an alternative
repair pathway, whereas Oxa is apparently not repaired by
BER and thus probably processed by an alternative repair
pathway (15), albeit slowly.
Oxa produced by nitrosative stress reacts further with
polyamines and DNA binding proteins in cells to form
cross-link adducts (25). Therefore, we have examined whether
DNA glycosylases can remove cross-link adducts from DNA
using Oxa–Sp-containing DNA as a representative adduct.
However, none of the DNA glycosylases tested were able to
remove Oxa–Sp from DNA (Table 2). We reason that DNA
glycosylases that recognize relatively minor base modiﬁca-
tions cannot accommodate the bulky Oxa–Sp adduct in the
active site pocket. Accordingly, we examined the excision
capacity of NER systems for Oxa–Sp that can recognize
bulky adducts, such as UV-induced pyrimidine dimers and
polycyclic aromatic hydrocarbon adducts (1,54,55,59,60). In
keeping with the damage speciﬁcity, UvrABC, the prokaryotic
NER system, made dual incisions on DNA containing Oxa–Sp
but not Oxa (Figure 3A and B), resulting in a 12mer fragment
bearing Oxa–Sp. The incision of Oxa–Sp DNA by UvrABC
was fairly efﬁcient (Figure 3C). The speciﬁc incision by
UvrABC was further substantiated by CFEs from SOS-
induced E.coli where the transcription of the uvrA and uvrB
genes are activated (Figure 3D). Previous genetic analyses of
E.coli strains defective in various DNA repair pathways sug-
gest that NER and recombination repair constitute a defense
mechanism against the genotoxic effects conferred by NO and
nitrous acid (11,61–64). Nitrosative stress also induce the SOS
response in Salmonella enterica, though the response seems
to be attributable to the inhibition of DNA replication due to
zinc mobilization rather than DNA damage (65). Assuming a
similar response to NO in E.coli, it is possible that UvrABC
contributes to the defense against nitrosative stress by
removing genotoxic cross-link adducts.
We have also found that DNA containing Oxa–Sp is spe-
ciﬁcally incised by CFE2s from NER-proﬁcient HeLa cells
(Figure 4D), and that the incision efﬁciency for Oxa–Sp is
comparable to that for FL (a control substrate) (Figure 4B).
Thecoupleddual incisions andtheir sites observed forOxa–Sp
(Figure 4C) are characteristic of the human NER system
(1,53–55). Together with the activity complementation experi-
ments with XPA and XPF CFE2s (Figure 4D), the present data
demonstrate that Oxa–Sp is processed by the NER system in
human cells when the lesion is generated by NO. Conversely,
in keeping with its non-bulky nature, Oxa-containing DNA
was not cleaved by human CFE2s. In this study, we have not
tested Oxa-protein cross-link adducts for NER enzymes or
CFEs, which are more bulky than Oxa–Sp. It has been recently
shown that UvrABC nuclease makes dual incisions on a sub-
strate containing a cross-link adduct between DNA and phage
T4 Endo V, which was prepared by the borohydride trapping
of a reaction intermediate (66,67). This suggests that Oxa–
protein cross-links adducts generated by nitrosative stress
could be processed similarly by the NER pathway.
In summary, we have analyzed the excision activity of
E.coli and human BER and NER enzymes for Oxa and
Oxa–Sp. Oxa is poorly excised from DNA by BER and NER
enzymes, whereas DNA containing Oxa–Sp is efﬁciently
incised by NER but not BER enzymes. Combining the present
and published data on the repair of guanine lesions generated
by nitrosative stress (Xan, Oxa and Oxa–Sp), Xan is repaired
by the BER pathway (or an alternative repair pathway in
E.coli), and the Oxa–Sp cross-link adduct is repaired by the
NER pathway. The repair mechanism of Oxa remains to be
established and further studies are necessary.
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